Association between virus variants, vaccination, previous infections, and post-COVID-19 risk

Objectives: The SARS-CoV-2 Omicron variant has spread rapidly and has been the dominant variant since 2022. The course of acute infection, in a vaccinated population, with Omicron is milder compared with earlier variants. However, little is known about how the occurrence of long-term symptoms after...

Full description

Bibliographic Details
Main Authors: Sophie Diexer, Bianca Klee, Cornelia Gottschick, Chao Xu, Anja Broda, Oliver Purschke, Mascha Binder, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Irene Moor, Michael Gekle, Rafael Mikolajczyk
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223007026
_version_ 1797682872789762048
author Sophie Diexer
Bianca Klee
Cornelia Gottschick
Chao Xu
Anja Broda
Oliver Purschke
Mascha Binder
Thomas Frese
Matthias Girndt
Jessica I. Hoell
Irene Moor
Michael Gekle
Rafael Mikolajczyk
author_facet Sophie Diexer
Bianca Klee
Cornelia Gottschick
Chao Xu
Anja Broda
Oliver Purschke
Mascha Binder
Thomas Frese
Matthias Girndt
Jessica I. Hoell
Irene Moor
Michael Gekle
Rafael Mikolajczyk
author_sort Sophie Diexer
collection DOAJ
description Objectives: The SARS-CoV-2 Omicron variant has spread rapidly and has been the dominant variant since 2022. The course of acute infection, in a vaccinated population, with Omicron is milder compared with earlier variants. However, little is known about how the occurrence of long-term symptoms after Omicron infection compared with other variants is modulated by previous infections and/or vaccinations. Methods: Participants of the DigiHero study provided information about their SARS-CoV-2 infections, vaccinations, and symptoms 12 or more weeks after infection (post-COVID-19 condition - PCC). Results: Participants infected with wildtype SARS-CoV-2 had the highest PCC risk (adjusted odds ratio [aOR] 6.44, 95% confidence interval (CI): 5.49; 7.56), followed by participants infected with Alpha and Delta compared with the reference group (individuals infected with Omicron having received three or more vaccinations). Among those infected with a specific variant, the number of preceding vaccinations was not associated with a risk reduction for PCC, whereas previous infection was strongly associated with a lower PCC risk (aOR 0.14, 95% CI 0.07; 0.25). Conclusions: While infection with Omicron is less likely to result in PCC compared with previous variants, lack of protection by vaccination suggests a substantial challenge for the healthcare system during the early endemic period. In the midterm, the protective effects of previous infections can reduce the burden of PCC.
first_indexed 2024-03-12T00:06:13Z
format Article
id doaj.art-6fb707e54af2414ebe7b297235188f3b
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-03-12T00:06:13Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-6fb707e54af2414ebe7b297235188f3b2023-09-17T04:55:56ZengElsevierInternational Journal of Infectious Diseases1201-97122023-11-011361421Association between virus variants, vaccination, previous infections, and post-COVID-19 riskSophie Diexer0Bianca Klee1Cornelia Gottschick2Chao Xu3Anja Broda4Oliver Purschke5Mascha Binder6Thomas Frese7Matthias Girndt8Jessica I. Hoell9Irene Moor10Michael Gekle11Rafael Mikolajczyk12Institute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Internal Medicine IV, Oncology/Haematology, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute of General Practice and Family Medicine, Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyDepartment of Internal Medicine II, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyPaediatric Haematology and Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Sociology, Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyJulius-Bernstein-Institute of Physiology, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), GermanyInstitute for Medical Epidemiology, Biometrics, and Informatics (IMEBI), Interdisciplinary Centre for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; Corresponding author:Objectives: The SARS-CoV-2 Omicron variant has spread rapidly and has been the dominant variant since 2022. The course of acute infection, in a vaccinated population, with Omicron is milder compared with earlier variants. However, little is known about how the occurrence of long-term symptoms after Omicron infection compared with other variants is modulated by previous infections and/or vaccinations. Methods: Participants of the DigiHero study provided information about their SARS-CoV-2 infections, vaccinations, and symptoms 12 or more weeks after infection (post-COVID-19 condition - PCC). Results: Participants infected with wildtype SARS-CoV-2 had the highest PCC risk (adjusted odds ratio [aOR] 6.44, 95% confidence interval (CI): 5.49; 7.56), followed by participants infected with Alpha and Delta compared with the reference group (individuals infected with Omicron having received three or more vaccinations). Among those infected with a specific variant, the number of preceding vaccinations was not associated with a risk reduction for PCC, whereas previous infection was strongly associated with a lower PCC risk (aOR 0.14, 95% CI 0.07; 0.25). Conclusions: While infection with Omicron is less likely to result in PCC compared with previous variants, lack of protection by vaccination suggests a substantial challenge for the healthcare system during the early endemic period. In the midterm, the protective effects of previous infections can reduce the burden of PCC.http://www.sciencedirect.com/science/article/pii/S1201971223007026SARS-CoV-2COVID-19SARS-CoV-2 variantsVaccination
spellingShingle Sophie Diexer
Bianca Klee
Cornelia Gottschick
Chao Xu
Anja Broda
Oliver Purschke
Mascha Binder
Thomas Frese
Matthias Girndt
Jessica I. Hoell
Irene Moor
Michael Gekle
Rafael Mikolajczyk
Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
International Journal of Infectious Diseases
SARS-CoV-2
COVID-19
SARS-CoV-2 variants
Vaccination
title Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
title_full Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
title_fullStr Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
title_full_unstemmed Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
title_short Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
title_sort association between virus variants vaccination previous infections and post covid 19 risk
topic SARS-CoV-2
COVID-19
SARS-CoV-2 variants
Vaccination
url http://www.sciencedirect.com/science/article/pii/S1201971223007026
work_keys_str_mv AT sophiediexer associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT biancaklee associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT corneliagottschick associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT chaoxu associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT anjabroda associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT oliverpurschke associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT maschabinder associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT thomasfrese associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT matthiasgirndt associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT jessicaihoell associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT irenemoor associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT michaelgekle associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk
AT rafaelmikolajczyk associationbetweenvirusvariantsvaccinationpreviousinfectionsandpostcovid19risk